ENDRA Life Sciences Inc. (NASDAQ:NDRA) Short Interest Down 75.2% in April

ENDRA Life Sciences Inc. (NASDAQ:NDRA) saw a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 7,600 shares, a drop of 75.2% from the March 31st total of 30,600 shares. Approximately 0.1% of the shares of the company are sold short. Based on an average trading volume of 169,800 shares, the days-to-cover ratio is currently 0.0 days.

ENDRA Life Sciences Stock Down 6.7 %

Shares of NDRA stock traded down $0.02 during mid-day trading on Thursday, reaching $0.24. The stock had a trading volume of 35,436 shares, compared to its average volume of 162,974. The firm’s 50 day simple moving average is $0.77 and its 200 day simple moving average is $1.07. ENDRA Life Sciences has a one year low of $0.22 and a one year high of $2.79. The firm has a market cap of $2.68 million, a PE ratio of -0.13 and a beta of 0.98.

ENDRA Life Sciences (NASDAQ:NDRA) last announced its quarterly earnings data on Thursday, March 28th. The company reported ($0.17) EPS for the quarter.

About ENDRA Life Sciences

ENDRA Life Sciences Inc develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.